Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Shijiazhuang Yiling Pharmaceutical Co Ltd

+ Add to Watchlist

002603:CH

27.300 CNY 2.980 9.84%

As of 03:00:27 ET on 05/28/2015.

Snapshot for Shijiazhuang Yiling Pharmaceutical Co Ltd (002603)

Open: 30.280 Day's Range: 27.250 - 30.790 Volume: 37,610,508
Previous Close: 30.280 52wk Range: 14.070 - 30.790 1-Yr Rtn: +81.99%

Stock Chart for 002603

No chart data available.
  • 002603:CH 27.300
  • 1D
  • 1M
  • 1Y
30.280
Interactive 002603 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002603

Current P/E Ratio (ttm) 86.6667
Estimated P/E(12/2015) 66.2621
Relative P/E vs. SZASHR 1.1979
Earnings Per Share (CNY) (ttm) 0.3150
Est. EPS (CNY) (12/2015) 0.4120
Est. PEG Ratio -
Market Cap (M CNY) 30,761.09
Shares Outstanding (M) 1,126.78
30 Day Average Volume 20,080,170
Price/Book (mrq) 6.7546
Price/Sale (ttm) 10.6592
Dividend Indicated Gross Yield 0.18%
Cash Dividend (CNY) 0.0500
Dividend Ex-Date 05/20/2015
5 Year Dividend Growth -
Next Earnings Announcement 08/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002603

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 002603

Shijiangzhuang Yiling Pharmaceutical Company Limited develops, produces and sells Chinese patent medicine. The Company's major products include Tongxinluo capsules, Shensongyangxin capsules, Lotus Qingwen capsules, Qili Qiangxin capsules and Bazi Bushen capsules.

Wu YilingChairmanWu XiangjunPresident
Wang WeipingVice PresidentDai FengxiangVP/Principal:Financial
More Company Profile & Key Executives for 002603

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil